Wed, Jul 23, 2014, 12:16 AM EDT - U.S. Markets open in 9 hrs 14 mins


% | $
Click the to save as a favorite.

Novadaq Technologies Inc. Message Board

gopointers2 4 posts  |  Last Activity: May 20, 2014 11:13 AM Member since: Oct 24, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • gopointers2 gopointers2 May 20, 2014 11:13 AM Flag

    You're correct. On November 7, 2013 Novadaq entered an agreement with Swissray Asia to become the exclusive distributor of Novadaq products in Australia and Indonesia as well as other SE Asia and Oceania countries. It said that there has been an agreement on minimum annual purchase commitments but Arun has never mentioned these publicly, to my knowlege.

    They also have an agreement with CHC Healthcare to distribute their products in China and Taiwan, once again with minimum annual purchases required. CHC hoped to begin importation into Taiwan as soon as they receive government approval, possibly by the end of Q2 2014 and in China possibly by Q3 2014.

    So, Novadaq is moving ahead on the international front. Maybe he will address any approvals in the next CC. I really would like to see an agreement to distribute in Japan, but maybe that is covered by the Swissray Asia agreement. Japan is a huge sales opportunity, just like it is for Intuitive, and I'd like to see the approval process get started there ASAP.

  • Reply to

    Analysis of Q1 2014 NVDQ Results

    by andersongordon May 7, 2014 7:33 AM
    gopointers2 gopointers2 May 9, 2014 1:40 PM Flag

    The main revenue driver is going to be PINPOINT and LUNA. Novadaq doesn't get much revenue from Intuitive and while it sounded like LifeCell had good procedure numbers their inventory purchases were way down.

    I was a little surprised by the $4.6M in PINPOINT and LUNA sales. That's up 39% just from last quarter. The direct sales team is starting to ramp up sales. Arun said 65 salespeople at the end of Q1, about 70 as of the CC and "triple digits" by the end of the year, with a long-term goal of 150-200, with a transition from capital sales to utilization sales. I think as these salespeople get up to speed (which Arun said was 9 months to get to "productive stage"), we are going to see rapidly-expanding revenue growth, likely starting a bit in Q3 but by Q4 for sure.

    I guess with the share price dropping so much so far this quarter we should see non-cash warrant revaluation expense decline quite a bit, so the Q2 loss might not be as bad. I really think that Q4 is where Novadaq finally may become profitable, but with a 50%+ increase in current salesperson numbers by the end of the year, that may get pushed back into 2015. However, even with the less-than-ideal revenue numbers I am very excited about the next few years.

  • Reply to

    what worries me

    by e11ndofwar Apr 29, 2014 12:53 PM
    gopointers2 gopointers2 May 1, 2014 11:15 AM Flag

    Novadaq has also mentioned that equipment sales can take more than a quarter to close, so Q1 may not be as affected by the ACA as Q2 or Q3.

  • Reply to

    what worries me

    by e11ndofwar Apr 29, 2014 12:53 PM
    gopointers2 gopointers2 Apr 29, 2014 4:49 PM Flag

    Yeah. I think that they pre-announced January 14th because they were presenting at the JP Morgan Healthcare Conference later that day.

16.70+0.09(+0.54%)Jul 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.